Predictors of frequency of CF care in the US Cystic Fibrosis Foundation Patient Registry

Alexandra C Hinton1,2, Edmund H Sears3, Jonathan B Zuckerman3

  • 1Center for Interdisciplinary Population and Health Research, MaineHealth Institute for Research, Scarborough, Maine, United States of America.

Plos One
|December 3, 2024
PubMed

Insights

Gaps in cystic fibrosis (CF) care are common, especially for males, non-white individuals, and the uninsured. Understanding these disparities is crucial for improving CF care and outcomes for all patients.

Area of Science:

  • Pulmonary Medicine
  • Health Services Research
  • Clinical Epidemiology

Background:

  • Prolonged gaps in care (>12 months) are frequent among people with cystic fibrosis (pwCF).
  • These care gaps are linked to reduced lung function and poorer health outcomes.
  • Identifying patient-level predictors of visit frequency is essential for optimizing care and ensuring equitable treatment.

Purpose of the Study:

  • To identify sociodemographic and disease-related factors associated with visit frequency in pwCF.
  • To analyze how these factors influence visit frequency across different age groups.
  • To inform strategies for reducing care gaps and improving health equity in CF care.

Main Methods:

  • An observational cohort study utilizing data from 2004-2016 from the US Cystic Fibrosis Foundation Patient Registry.
  • Inclusion of 28,588 pwCF aged 6-60 years.
  • Multivariable longitudinal semiparametric regression modeling to analyze the relationship between patient characteristics and between-visit interval (BVI).

Main Results:

  • Males and non-white individuals exhibited longer BVIs compared to females and white individuals, respectively, with disparities most pronounced in young adults.
  • Uninsured individuals over age 25 had significantly longer BVIs (≥30 days) than insured patients.
  • While most insured individuals adhered to guidelines, adults without CF complications had longer BVIs (≥110 days) from age 23-56.

Conclusions:

  • Less frequent clinic visits in males, non-white individuals, and uninsured patients may indicate patient preference or structural barriers to care.
  • Frequent visits among those with CF complications likely reflect higher healthcare needs.
  • These findings highlight critical risk factors for care gaps that should guide revisions to CF care recommendations to promote equitable outcomes.
Abstract

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
186
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
141
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.5K
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
2.5K
Pulmonary Function Tests01:25

Pulmonary Function Tests

Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
308